Findings independent of other established risk factors
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
In-Utero Sugar Restriction Cuts Offspring’s Risk for Diabetes, Hypertension
35 percent lower risk for diabetes, 20 percent reduced risk for hypertension seen for sugar restriction in first three years after conception